Double Bond Pharmaceutical Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 11
Employees
  • Stock Symbol
  • DBP B
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.25
  • (As of Friday Closing)

Double Bond Pharmaceutical General Information

Description

Double Bond Pharmaceutical International AB is a pharmaceutical company. The company develops and commercializes approaches for the treatment of cancers, infections, autoimmune diseases, and other life-threatening disorders.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
SAT
Primary Office
  • Virdings allé 32B
  • 754 50 Uppsala
  • Sweden
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Double Bond Pharmaceutical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.25 $0.26 $0.13 - $0.60 $8.77M 43.3M 71.2K -$0.04

Double Bond Pharmaceutical Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 12,983 8,934 15,378 8,419
Revenue 97 26 2 0
EBITDA (1,430) (847) (1,247) (1,504)
Net Income (1,425) (827) (1,274) (1,520)
Total Assets 2,517 961 623 291
Total Debt 0 0 2 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Double Bond Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Double Bond Pharmaceutical‘s full profile, request access.

Request a free trial

Double Bond Pharmaceutical Executive Team (1)

Name Title Board Seat Contact Info
Igor Lokot Ph.D Chief Executive Officer & Board Member
To view Double Bond Pharmaceutical’s complete executive team members history, request access »

Double Bond Pharmaceutical Board Members (1)

Name Representing Role Since
0000 00000 00.0 Double Bond Pharmaceutical Chief Executive Officer & Board Member 000 0000
To view Double Bond Pharmaceutical’s complete board members history, request access »

Double Bond Pharmaceutical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Double Bond Pharmaceutical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Double Bond Pharmaceutical‘s full profile, request access.

Request a free trial

Double Bond Pharmaceutical Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 (000 01-Oct-2015 000000000 00000 00 Buildings and Property
To view Double Bond Pharmaceutical’s complete investments history, request access »